E. Sanders

发表

Efficacy of rifampin in treatment of meningococcal carriers.

W. Deal, E. Sanders, 1969, The New England journal of medicine.

The Mycobacterium tuberculosis 38-kDa antigen: overproduction in Escherichia coli, purification and characterization.

K. Timmis, M. Rohde, J. McCarthy, 1992, Gene.

Sisomicin: Evaluation In Vitro and Comparison with Gentamicin and Tobramycin

C. Crowe, E. Sanders, Christine C. Crowe, 1973, Antimicrobial Agents and Chemotherapy.

Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci.

E. Sanders, Eugene Sanders, 1969, The Journal of infectious diseases.

Is There Complete Cross-Resistance of Gram-Negative Bacilli to Gentamicin and Tobramycin?

C. Crowe, E. Sanders, 1972, Antimicrobial Agents and Chemotherapy.

Lincomycin versus erythromycin: a choice or an echo.

E. Sanders, 1969, Annals of internal medicine.

Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.

M. T. Foster, D. Scott, E. Sanders, 1968, The New England journal of medicine.

Inhibition of meningococci by new antimicrobial agents in vitro and recognition of a class of sulfones with a unique mechanism of antibacterial activity.

W. Deal, E. Sanders, 1970, Antimicrobial agents and chemotherapy.

Prevention of meningococcal infections.

W. Deal, E. Sanders, 1970, The Journal of infectious diseases.

Remediable causes of failure of "appropriate" antimicrobial therapy.

E. Sanders, P. Jurgensen, 1971, Postgraduate medicine.